NF-κB is a target for the development of therapeutic strategies, including new natural molecules with the ability to regulate this aberrant signaling and contribute to cancer cell apoptosis, especially in advanced prostate cancer [11,12,13]. The gene discussed is NFKB1; the disease is prostate carcinoma.